Intelligencia-logo-color-@1x (1).png
Intelligencia AI Ranks No. 90 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies  
March 20, 2024 09:18 ET | Intelligencia AI
Inc. magazine recently revealed that Intelligencia AI, a provider of AI-powered decision-making solutions for the pharmaceutical industry, ranks No. 90.
22157.jpg
Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029: 800+ Bispecific Candidates Currently in Active Clinical Development
March 18, 2024 05:16 ET | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...
Global Contract Research Organization Services Market
Global Contract Research Organization Services Market Analysis & Forecast to 2023-2033: Pharmaceutical Giants Ramp Up Investments Amidst Rising Chronic Disease Burden
March 13, 2024 12:01 ET | Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Contract Research Organization Services Market Analysis & Forecast to 2023-2033: Market By Service; By Application; By End-user; and By...
22157.jpg
Global DLL3 Targeted Therapy Market Research Report 2024 - Innovations, Opportunities, Market Trends & Clinical Trials Insights
February 01, 2024 03:16 ET | Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Imutex's FLU-v Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032: Focus on United States,Germany, France, Italy, Spain, United Kingdom, and Japan
January 31, 2024 04:06 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "FLU-v Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
22157.jpg
VBI-1901 Drug and Market Analysis Report 2023-2032: Mechanism of Action, Clinical Trials, Collaborations, and Market Projections for a Promising GBM Therapy
January 30, 2024 10:59 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "VBI-1901 Emerging Drug Insight and Market Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report provides an...
22157.jpg
MGB-BP-3 Drug and Market Analysis 2023-2032: A Promising Treatment for Clostridium Difficile Infection (CDI)
January 30, 2024 10:54 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MGB-BP-3 Emerging Drug Insight and Market Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report provides an...
22157.jpg
MPH966 (Alvelestat) Drug Insight with Market Projections to 2032: A Novel Therapy Under Development for Bronchiolitis Obliterans Syndrome (BOS)
January 30, 2024 10:51 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MPH966 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers an in-depth...
22157.jpg
MTG201 + Nivolumab Drug and Market Analysis 2023-2032: Sales Analytics, Clinical Assessment, SWOT Analysis, Emerging Competitors
January 30, 2024 10:50 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MTG201 + nivolumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides...
22157.jpg
Analysis of INOVIO's INO-5401 & INO-9012 and Regeneron & Sanofi's LIBTAYO (Cemiplimab) Treatment for Glioblastoma Multiforme (GBM): Drug Insights, Regulatory Landscape, and Market Forecast to 2032
January 30, 2024 07:29 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "INO-5401 + INO-9012 + LIBTAYO Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This...